A detailed history of Charles Schwab Investment Management Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 251,995 shares of STRO stock, worth $486,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
251,995
Previous 216,828 16.22%
Holding current value
$486,350
Previous $635,000 37.17%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.88 - $5.01 $101,280 - $176,186
35,167 Added 16.22%
251,995 $871,000
Q2 2024

Aug 12, 2024

BUY
$2.92 - $5.33 $163,379 - $298,224
55,952 Added 34.78%
216,828 $635,000
Q2 2023

Aug 09, 2023

BUY
$4.25 - $5.88 $63,478 - $87,823
14,936 Added 10.23%
160,876 $748,000
Q1 2023

May 11, 2023

BUY
$4.48 - $8.45 $8,032 - $15,150
1,793 Added 1.24%
145,940 $674,000
Q4 2022

Feb 13, 2023

BUY
$5.41 - $8.08 $70,016 - $104,571
12,942 Added 9.86%
144,147 $1.16 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $59,051 - $81,210
11,422 Added 9.54%
131,205 $729,000
Q2 2022

Aug 15, 2022

BUY
$3.41 - $8.95 $395 - $1,038
116 Added 0.1%
119,783 $625,000
Q1 2022

May 13, 2022

BUY
$7.78 - $15.31 $78,718 - $154,906
10,118 Added 9.24%
119,667 $984,000
Q4 2021

Feb 11, 2022

BUY
$14.25 - $23.53 $23,883 - $39,436
1,676 Added 1.55%
109,549 $1.63 Million
Q3 2021

Nov 16, 2021

BUY
$16.88 - $22.38 $65,409 - $86,722
3,875 Added 3.73%
107,873 $2.04 Million
Q2 2021

Aug 16, 2021

BUY
$18.03 - $23.82 $407,478 - $538,332
22,600 Added 27.76%
103,998 $1.93 Million
Q1 2021

May 17, 2021

BUY
$20.29 - $27.54 $226,700 - $307,704
11,173 Added 15.91%
81,398 $1.85 Million
Q4 2020

Feb 16, 2021

BUY
$10.16 - $23.98 $44,358 - $104,696
4,366 Added 6.63%
70,225 $1.53 Million
Q3 2020

Nov 13, 2020

BUY
$7.44 - $13.15 $131,152 - $231,808
17,628 Added 36.55%
65,859 $662,000
Q2 2020

Aug 14, 2020

BUY
$7.24 - $11.05 $185,626 - $283,310
25,639 Added 113.49%
48,231 $375,000
Q2 2019

Aug 09, 2019

BUY
$9.69 - $12.23 $91,880 - $115,964
9,482 Added 72.33%
22,592 $258,000
Q4 2018

Feb 14, 2019

BUY
$8.69 - $14.85 $113,925 - $194,683
13,110 New
13,110 $119,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $101M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.